Has HIV evolved to induce immune pathogenesis?

Trends in Immunology

Volumn 29, Issue 7, 2008, Pages 322-328

  Bartha, István ^a   Simon, Péter ^a   Müller, Viktor ^a  

^a EÖTVÖS LORÁND UNIVERSITY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CD4+ T LYMPHOCYTE; EVOLUTION; EVOLUTIONARY ADAPTATION; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE RESPONSE; IMMUNOPATHOLOGY; LYMPH FOLLICLE; MATHEMATICAL MODEL; NONHUMAN; T LYMPHOCYTE ACTIVATION; VIRUS MUTATION; VIRUS TRANSMISSION;

CD4-POSITIVE T-LYMPHOCYTES; EVOLUTION; HIV INFECTIONS; HUMANS; LYMPHOCYTE ACTIVATION; MODELS, IMMUNOLOGICAL; MUTATION;

EID: 45549105435     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.it.2008.04.005     Document Type: Article

References (60)

1. Ascher M.S., and Sheppard H.W. AIDS as immune system activation: a model for pathogenesis. Clin. Exp. Immunol. 73 (1988) 165-167
2. Hazenberg M.D., et al. T cell depletion in HIV-1 infection: how CD4+ T cells go out of stock. Nat. Immunol. 1 (2000) 285-289
3. Lawn S.D., et al. Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infection. Clin. Microbiol. Rev. 14 (2001) 753-777
4. Grossman Z., et al. CD4+ T-cell depletion in HIV infection: are we closer to understanding the cause?. Nat. Med. 8 (2002) 319-323
5. Giorgi J.V., et al. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J. Infect. Dis. 179 (1999) 859-870
6. Leng Q., et al. Immune activation correlates better than HIV plasma viral load with CD4 T-cell decline during HIV infection. J. Acquir. Immune Defic. Syndr. 27 (2001) 389-397
7. Hazenberg M.D., et al. Persistent immune activation in HIV-1 infection is associated with progression to AIDS. AIDS 17 (2003) 1881-1888
8. Deeks S.G., et al. Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load. Blood 104 (2004) 942-947
9. Sousa A.E., et al. CD4 T cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to the viral load. J. Immunol. 169 (2002) 3400-3406
10. McCune J.M. The dynamics of CD4+ T-cell depletion in HIV disease. Nature 410 (2001) 974-979
11. Gao F., et al. Human infection by genetically diverse SIVSM-related HIV-2 in west Africa. Nature 358 (1992) 495-499
12. Gao F., et al. Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature 397 (1999) 436-441
13. Rey-Cuille M.A., et al. Simian immunodeficiency virus replicates to high levels in sooty mangabeys without inducing disease. J. Virol. 72 (1998) 3872-3886
14. Silvestri G., et al. Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia. Immunity 18 (2003) 441-452
15. Hirsch V.M. What can natural infection of African monkeys with simian immunodeficiency virus tell us about the pathogenesis of AIDS?. AIDS Rev. 6 (2004) 40-53
16. Finzi D., et al. Defective virus drives human immunodeficiency virus infection, persistence, and pathogenesis. Clin. Vaccine Immunol. 13 (2006) 715-721
17. Biancotto A., et al. HIV-1-induced activation of CD4+ T cells creates new targets for HIV-1 infection in human lymphoid tissue ex vivo. Blood 111 (2008) 699-704
18. Zack J.A., et al. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 61 (1990) 213-222
19. Bukrinsky M.I., et al. Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection. Science 254 (1991) 423-427
20. Chiu Y.L., et al. Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells. Nature 435 (2005) 108-114
21. Zhang Z., et al. Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells. Science 286 (1999) 1353-1357
22. Zhang Z.Q., et al. Roles of substrate availability and infection of resting and activated CD4+ T cells in transmission and acute simian immunodeficiency virus infection. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 5640-5645
23. Douek D.C., et al. HIV preferentially infects HIV-specific CD4+ T cells. Nature 417 (2002) 95-98
24. Brenchley J.M., et al. Preferential infection shortens the life span of human immunodeficiency virus-specific CD4+ T cells in vivo. J. Virol. 80 (2006) 6801-6809
25. Pitcher C.J., et al. HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression. Nat. Med. 5 (1999) 518-525
26. O'Brien W.A., et al. Human immunodeficiency virus-type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination. Blood 86 (1995) 1082-1089
27. Staprans S.I., et al. Activation of virus replication after vaccination of HIV-1-infected individuals. J. Exp. Med. 182 (1995) 1727-1737
28. Bush C.E., et al. A study of HIV RNA viral load in AIDS patients with bacterial pneumonia. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 13 (1996) 23-26
29. Goletti D., et al. Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation. J. Immunol. 157 (1996) 1271-1278
30. Mole L., et al. The impact of active herpes simplex virus infection on human immunodeficiency virus load. J. Infect. Dis. 176 (1997) 766-770
31. Ascher M.S., and Sheppard H.W. AIDS as immune system activation. II. The panergic imnesia hypothesis. J. Acquir. Immune Defic. Syndr. 3 (1990) 177-191
32. Swingler S., et al. HIV-1 Nef mediates lymphocyte chemotaxis and activation by infected macrophages. Nat. Med. 5 (1999) 997-1003
33. Biancotto A., et al. Abnormal activation and cytokine spectra in lymph nodes of people chronically infected with HIV-1. Blood 109 (2007) 4272-4279
34. Herbein G., and Khan K.A. Is HIV infection a TNF receptor signalling-driven disease?. Trends Immunol. 29 (2008) 61-67
35. Brenchley J.M., et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 12 (2006) 1365-1371
36. Meier A., et al. MyD88-dependent immune activation mediated by human immunodeficiency virus type 1-encoded Toll-like receptor ligands. J. Virol. 81 (2007) 8180-8191
37. Embretson J., et al. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 362 (1993) 359-362
38. Pantaleo G., et al. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 362 (1993) 355-358
39. Delassus S., et al. Nonhomogeneous distribution of human immunodeficiency virus type 1 proviruses in the spleen. J. Virol. 66 (1992) 5642-5645
40. Cheynier R., et al. HIV and T cell expansion in splenic white pulps is accompanied by infiltration of HIV-specific cytotoxic T lymphocytes. Cell 78 (1994) 373-387
41. Gratton S., et al. Highly restricted spread of HIV-1 and multiply infected cells within splenic germinal centers. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 14566-14571
42. Dumaurier M.J., et al. The majority of human immunodeficiency virus type 1 particles present within splenic germinal centres are produced locally. J. Gen. Virol. 86 (2005) 3369-3373
43. Grossman Z., et al. Multiple modes of cellular activation and virus transmission in HIV infection: a role for chronically and latently infected cells in sustaining viral replication. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 6314-6319
44. Grossman Z., et al. Pathogenesis of HIV infection: what the virus spares is as important as what it destroys. Nat. Med. 12 (2006) 289-295
45. Frost S.D., et al. Genetic drift and within-host metapopulation dynamics of HIV-1 infection. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 6975-6980
46. Potter S.J., et al. Genetic analyses reveal structured HIV-1 populations in serially sampled T lymphocytes of patients receiving HAART. Virology 348 (2006) 35-46
47. Shriner D., et al. Evolution of intrahost HIV-1 genetic diversity during chronic infection. Evolution Int. J. Org. Evolution 60 (2006) 1165-1176
48. Cheynier R., et al. Antigenic stimulation by BCG vaccine as an in vivo driving force for SIV replication and dissemination. Nat. Med. 4 (1998) 421-427
49. Wilson D.S. A theory of group selection. Proc. Natl. Acad. Sci. U. S. A. 72 (1975) 143-146
50. Wilson D.S. Structured demes and the evolution of group-advantageous traits. Am. Nat. 111 (1977) 157-185
51. Szathmary E. Natural selection and dynamical coexistence of defective and complementing virus segments. J. Theor. Biol. 157 (1992) 383-406
52. Bonhoeffer S., and Nowak M.A. Intra-host versus inter-host selection: viral strategies of immune function impairment. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 8062-8066
53. Müller V., and De Boer R.J. The integration hypothesis: an evolutionary pathway to benign SIV infection. PLoS Pathog. 2 (2006) e15
54. Fraser C., et al. Variation in HIV-1 set-point viral load: epidemiological analysis and an evolutionary hypothesis. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 17441-17446
55. Rambaut A., et al. The causes and consequences of HIV evolution. Nat. Rev. Genet. 5 (2004) 52-61
56. Wawer M.J., et al. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J. Infect. Dis. 191 (2005) 1403-1409
57. De Boer R.J., and Perelson A.S. Target cell limited and immune control models of HIV infection: a comparison. J. Theor. Biol. 190 (1998) 201-214
58. Yates A., et al. Understanding the slow depletion of memory CD4+ T cells in HIV infection. PLoS Med. 4 (2007) e177
59. Nowak M.A., and May R.M. Virus Dynamics: Mathematical Principles of Immunology and Virology (2000), Oxford University Press
60. Wodarz D., et al. Dynamics of macrophage and T cell infection by HIV. J. Theor. Biol. 196 (1999) 101-113